Plato Investment Management Ltd

Position in ABT — Abbott Laboratories

CIK 1984475 SYDNEY, C3

Position in ABT

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$4,047,548

-$516,030 QoQ

Shares Held

44,606

+0.4% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

#796

of 2,959 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Plato Investment Management Ltd holds $17,212,974 across 10 Medical Devices names. ABT ranks #1 (23.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories This page	44,606	$4,047,548
2	SYK	Stryker Corp	12,092	$3,807,045
3	MDT	Medtronic plc	46,948	$3,672,742
4	EW	Edwards Lifesciences Corp	22,627	$2,046,838
5	BSX	Boston Scientific Corp	30,788	$1,314,031
6	STE	STERIS plc	4,026	$847,754
7	DXCM	Dexcom Inc	11,681	$786,715
8	PODD	Insulet Corp	2,356	$358,701

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,047,548	44,606	+0.4%	Shares	Sole	2026-08-07
2026-03-31	$4,563,578	44,449	+4.1%	Shares	Sole	2026-05-05
2025-12-31	$5,347,502	42,681	0.0%	Shares	Sole	2026-02-04
2025-09-30	$5,716,693	42,681	0.0%	Shares	Sole	2025-11-05
2025-06-30	$5,805,042	42,681	+0.1%	Shares	Sole	2025-08-05
2025-03-31	$5,657,257	42,648	-4.2%	Shares	Sole	2025-05-20
2024-12-31	$5,034,526	44,510	0.0%	Shares	Sole	2025-02-06
2024-09-30	$5,074,585	44,510	0.0%	Shares	Sole	2024-11-06
2024-06-30	$4,625,034	44,510	+7.2%	Shares	Sole	2024-08-09
2024-03-31	$4,719,504	41,523	+1360.5%	Shares	Sole	2024-05-17
2023-12-31	$312,929	2,843	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.